A naukri.com initiative
TechBullion
4w
249
Image Credit: TechBullion
Unlocking the Power of Molecular Lab Data: An Interview with Noah Nasser, CEO of Datma
- Datma, a healthcare technology company, aims to utilize molecular lab data for research and patient outcomes.
- Noah Nasser, CEO of Datma, discusses datma.FED, a platform bridging data gap among labs, health systems, and pharmaceutical companies.
- datma.FED facilitates secure monetization of lab data for non-reimbursed tests while complying with privacy regulations like HIPAA.
- Datma provides structured datasets for pharma companies to enhance evidence generation and market strategies.
- With a federated model, Datma ensures data custodians retain control, promoting collaboration and driving healthcare advancements.
- Datma is expanding globally, investing in AI analytics, and launching solutions like datma.WHY and datma.360 for real-world evidence and personalized medicine.
- By automating data sharing securely, Datma overcomes barriers like privacy concerns and regulatory compliance in healthcare data collaboration.
- datma.FED provides high-resolution, tailored datasets for pharma companies, aiding in research, market access strategies, and clinical applications.
- Through controlled, query-based access, Datma's federated approach allows labs to monetize data without compromising privacy regulations.
- Datma emphasizes compliance and security in data sharing, implementing strict access controls and encryption measures.
Read Full Article
14 Likes
For uninterrupted reading, download the app